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Increasing interest is being shown in beating heart (off-pump) coronary artery surgery
(OPCAB) because, compared with operations performed with cardiopulmonary bypass,
OPCAB surgery may be associated with decreased postoperative morbidity and reduced total
costs. Its appears to produce better results than conventional surgery in high-risk patient popu-
lations, elderly patients, and those with compromised cardiac function or coagulation dis-
orders. Recent improvements in the technique have resulted in the possibility of multiple-
vessel grafting in all coronary territories, with a graft patency comparable with conventional
surgery. During beating-heart surgery, anaesthetists face two problems: ®rst, the maintenance
of haemodynamic stability during heart enucleation necessary for accessing each coronary
artery; and second, the management of intraoperative myocardial ischaemia when coronary
¯ow must be interrupted during grafting. The anaesthetic technique is less important than ade-
quate management of these two major constraints. However, experimental and recent clinical
data suggest that volatile anaesthetics have a marked cardioprotective effect against ischaemia,
and might be speci®cally indicated. OPCAB surgery requires team work between anaesthetists
and surgeons, who must be aware of each other's constraints. Some surgical aspects of the
operation are reviewed along with physiological and anaesthetic data.
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In the Western world, coronary artery bypass grafting
(CABG) is one of the most commonly performed cardiac
surgical procedures. In the last decade, there has been
renewed interest in performing CABG without cardiopul-
monary bypass (CPB). Avoiding CPB eliminates aortic
cannulation and cross-clamping, and is expected to reduce
systemic in¯ammatory response, coagulation disorders, and
multiple organ dysfunction.
Off-pump coronary revascularization is an old technique,
performed ®rst in St Petersburg in 1964,62 but was soon
outshone by the rapid development of CPB and cardiople-
gia. A revival of the technique occurred during the 1980s in
isolated series, and in centres where limited resources
favoured off-pump techniques. Accordingly, large series
have been undertaken in Buenos Aires (700 patients),12 SaÄo
Paulo (1274 patients),20 Ankara (2052 patients),114 and New
Dehli (2800 patients).116
Off pump coronary artery surgery has been developed
following two different approaches. Minimally invasive
direct-access coronary artery bypass (MIDCAB) consists of
anastomozing the left internal mammary artery to the left
anterior descending coronary artery through a small anterior
left thoracotomy. Nowadays, this technique has largely been
abandoned, because it allows only single vessel surgery, is
technically demanding, and may lead to suboptimal results.
Moreover, postoperative pain is usually more severe after
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thoracotomy than after sternotomy.39 The second approach
is multivessel grafting without CPB performed through a
standard median sternotomy, which gives access to all
coronary vessels, and allows standard techniques of mam-
mary artery harvesting. The recent introduction of sophis-
ticated stabilizing devices and exposure techniques13 has
resulted in an increased graft patency rate,25 and in the
widespread use of this technique for all coronary territories
and for as many anastomoses as needed to treat the patient's
coronary artery disease.4 106 This review will focus exclu-
sively on the latter procedure, called off-pump coronary
artery bypass (OPCAB).
Rationale for avoiding CPB
For more than 30 yr, extracorporeal circulation has been the
gold standard for CABG surgery. Despite the excellent
results and the low mortality of the procedure, postoperative
complications have continued to be a major concern.
Eliminating CPB might theoretically reduce, if not prevent,
some of these complications. Critical evaluation of the
available literature comparing surgical coronary revascular-
ization with or without bypass is hampered by two
important factors. First, although there are 14 randomized
and/or prospective controlled studies (level I or II of
evidence), the majority of the clinical studies is of low level
of evidence (level III to V) and include relatively small
numbers of patients, usually compared with historical data.
Moreover, they might be ¯awed by patient selection and
surgical treatment bias. Second, the learning curve of this
technically demanding novel approach and the usually small
number of anastomoses initially performed on each patient
in the early stages of its development, markedly affect the
results of the different centres.3 The impact of OPCAB
surgery on patient outcome, as judged by the end-points of
mortality and morbidity, is still debated. In an analysis of
the National Adult Cardiac Surgery Database totalling 3396
OPCAB procedures, the risk-adjusted mortality decreased
from 2.9% in conventional CABG to 2.3% in off-pump
procedures, and the complication rate from 12% to 8%.30
Some studies have shown similar results,3 22 95 96 109
whereas others demonstrate no difference in mortal-
ity,26 54 64 68 124 or morbidity.21 29 53 89 118 Nevertheless, the
need for transfusion is reduced in all centres.9 26 53 87 97 118
Compared with on-pump revascularization, OPCAB sur-
gery shows a slight trend towards fewer cardiac events for
up to 3 yr of follow-up.3 The results reported in the literature
so far are summarized in Table 1, where the level of
evidence of the studies is detailed.
The course of patients in the early postoperative period is
usually improved with OPCAB surgery compared with on-
pump surgery. The duration of ventilatory support, ICU
length of stay, and hospital length of stay are signi®cantly
diminished in almost every study.2 8 17 58 63 94 The overall
short-term cost is therefore decreased by 14% to
30%.7 8 65 67 89 96 Early outcomes and one-month graft
patency rates (94±99%) appear to be comparable with
those seen with conventional on-pump surgery, at least
when the surgical team has overcome the dif®culties of the
learning period.24 The long-term patency rate is still
unknown. The incidence of postoperative infarction,
depending on many intraoperative factors, does not show
striking differences between on-pump and off-pump tech-
niques, although myocardial enzymes and troponin I release
are reduced after off-pump surgery.5 15 97 118 The incidence
of atrial ®brillation is probably unchanged.84 110
The results are not clear-cut concerning neurological
outcome. Cross-clamping and cannulation of the ascending
aorta, as well as the ¯ow jet from the arterial cannula of
CPB, are eliminated in OPCAB surgery; this should reduce
the incidence of embolic events from the atheromatous
aorta.94 Although the total number of embolic events on
transcranial Doppler is effectively decreased,16 38 122 the
occurrence of strokes was only found to be signi®cantly
Table 1 Claimed advantages of OPCAB compared with CABG and CPB
Endpoints References supporting References disproving
Level of evidence I II III IV V I II III IV
¯ Global mortality 3 22 30 95 96 97 109 118 89 29 53 54 64 68 124 26
¯ Global morbidity 3 22 30 95 96 97 109 109 118 89 21 29 53 64
¯ Mortality in high-risk patients 1 4 106 100
¯ Morbidity in high-risk patients 112 126 83 114 100
¯ Mortality in elderly patients 63 111 2
¯ Morbidity in elderly patients 17 99 111 2
¯ In ICU/hospital length of stay 8 97 58 119 17 63 94 111 126 2 68 21
¯ Global cost 7 8 58 65 89 17 67 96 21
¯ Transfusion rate 9 97 65 118 16 53 64 87 97 26 114
¯ Infarction rate 3 97 22 15 63 26
¯ Stroke rate 38 16 36 93 94 99 116 4 29 54
¯ Neurological dysfunction 38 85 16 117 63 113
¯ Renal dysfunction 6 70 1 48 63
¯ Infections 8 96 33 1
­ Pulmonary function 8 65 32
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lower in isolated studies,93 94 116 or in octogenarians.36 99
The incidence of postoperative strokes may depend on the
manipulation of the ascending aorta for proximal anasto-
moses, and reduced stroke rates may be achieved by surgical
techniques avoiding aortic clamping completely, such as
branching bypass grafts on peripheral arteries emerging
from the aortic arch.23 24 The effect on cognition is also
debatable, because the few published studies show con¯ict-
ing results.38 63 85 113 117
There is increasing evidence that off-pump procedures
are associated with reduced postoperative rise in markers of
systemic in¯ammatory response (SIRS), such as C3a, C5a,
TNF-a, or interleukin (IL)-6 and IL-8.8 33 37 77 However, the
clinical signi®cance of these data is still uncertain, because
IL-8 and C3a are linked to the amount of surgical tissue
injury, IL-10 has anti-in¯ammatory properties, and heparin
inhibits complement activation.79 The effects of CPB on
SIRS depend largely on the balance between pro-in¯am-
matory and anti-in¯ammatory mediator release. As some
population subgoups might show a greater pro-in¯amma-
tory cytokine response, such as elderly patients or patients
with left ventricular (LV) dysfunction, they should bene®t
particularly from off-pump procedures.8 115
In a low-risk population, surgical coronary revasculariza-
tion, with or without CPB, has low morbidity and mortality
rates.89 Possible advantages of OPCAB surgery are there-
fore more likely to be found in high-risk patients with
signi®cant comorbidities and an expected mortality of 6±
10%.106 Mortality appears to be lower in some series,1 4 106
but not all89 100 (Table 1). In elderly patients, results are
improved with OPCAB surgery: mortality and post-
operative complication rates are signi®cantly
lower;17 63 99 111 the incidence of a low postoperative
cardiac output is reduced from 32% to 10%; and strokes
are reduced from 9% to 1%.2 17 36 99 Similarly, emergency
coronary surgery or surgery performed on patients with
impaired ventricular function (ejection fraction <0.35) have
shown encouraging results.83 112 126 Available reports show
only some trend toward possible renal protection, but there
is probably no difference for patients on dialysis.1 6 48 70 The
results concerning insulin-dependent diabetics show no
improvement in comparison with conventional surgery.4 83
OPCAB has been shown to be feasible in almost all
patients requiring coronary bypass. The only contraindica-
tions are the presence of intracavitary thrombi, malignant
ventricular arrhythmias, deep intramyocardial vessels, and
procedures combined with valve replacement or ventricular
aneurysmectomy. Despite dif®culties because of pericardial
adhesions, beating-heart reoperations for single- and mul-
tiple-vessel disease have been performed through thoracot-
omy or sternotomy incisions.80
Problems associated with OPCAB
During beating-heart surgery, the surgeon is faced with two
main problems: ®rst, to obtain an adequate exposure of the
anastomosis site with restrained cardiac motion; and second,
to protect the myocardium from ischaemia during coronary
artery ¯ow interruption. For these purposes, he must
displace the heart, compress the ventricular wall, and if
possible use a technique to allow coronary perfusion while
performing the anastomoses. Thus, the anaesthetist must be
prepared to handle severe haemodynamic alterations, tran-
sient deterioration of cardiac pump function, and acute
intraoperative myocardial ischaemia. The team must be
prepared for conversion to CPB in case of sustained
ventricular ®brillation or cardiovascular collapse.
Haemodynamic alterations with cardiac
manipulation
Surgical access to the left anterior descending coronary
artery is relatively easy through a median sternotomy but, in
order to work on the posterior or lateral walls, the heart must
be lifted and tilted out of the pericardial cradle. This
displacement of the heart has important haemodynamic
consequences, resulting in a signi®cant increase in atrial
pressures, and a marked decrease in cardiac output (cardiac
index <2 litre min±1 m±2), leading to a reduced mixed-
venous saturation (SvO2), often <70%. Different parts of the
procedure produce different haemodynamic disturbances.
First, the heart is tilted in a vertical position with the apex
at its zenith; the atria are then situated below the corres-
ponding ventricles, and the blood must ¯ow up into the
ventricular cavities. Therefore, the ®lling pressures, as
measured in the right and left atria, are increased much more
than the corresponding ventricular end-diastolic pressures,78
and must be maintained at a higher than normal level to
Fig 1 Changes in volume of the left atrium and the left ventricle during
heart verticalization. (A) TOE two-chamber view at 90° of the patient's
heart in its supine position. The left atrial (LA) volume is about one-third
of the left ventricular (LV) volume. (B) Without modifying the position
of the TOE probe, the heart has been lifted up in a vertical position in
order to operate on its postero-inferior wall. The relative dimensions of
LA and LV in this new 90° two-chamber view are reversed: the atrium,
being now under the ventricle, is larger than the ventricle in which the
end-diastolic volume is reduced by 50%. Both pictures are taken in
protosystole.
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maintain ventricular ®lling.90 The atrial size can increase by
50% and become larger than the ventricle (Fig. 1).49 78
Mitral and pulmonary venous ¯ows show patterns of
impaired diastolic ®lling and moderate diastolic dysfunc-
tion.49
Second, the stabilizer device used to immobilize the area
of the anastomosis pushes on the ventricular wall, restricts
local motion and decreases ventricular dimensions. The
location of the stabilizer device, combined with the degree
of heart dislocation, determine the overall effect on global
cardiac output. As the anterior and lateral walls have wider
displacement in systole and diastole than the septal and
posteroinferior walls, their contribution to stroke volume is
predominant. Compression on the anterior and lateral walls
has therefore more serious haemodynamic consequences
than compression on the posterior wall. The most profound
disturbances are observed during lateral wall exposure for
anastomosis on the circum¯ex artery because the heart is
then lifted more extensively than for surgery on the left
anterior descending artery.49 78 84
Third, a vertical position of the heart induces distortions
of the mitral and tricuspid annuli, as the intracardiac
structures are folded primarily at the atrioventricular
groove. The annular plane of the valves is modi®ed, and
signi®cant regurgitation may occur. The mitral annulus,
reconstructed in three dimensions with transoesophageal
echocardiographic (TOE) monitoring, is bent over, folded
and twisted.49 This may result in signi®cant mitral and
tricuspid regurgitation (Figs 2 and 3). The sudden appear-
ance of large `v' waves (>30 mm Hg) on the pulmonary
artery catheter readings, without signs of LV failure,
illustrates the same mechanism. The distortion of the
atrioventricular annulus can also result in a functional
stenosis. The most profound effect seems to occur on
abnormal valves, which become more distorted. The same
phenomenon may be observed on the aortic valve; a trivial
aortic regurgitation may become severe when the heart is
`enucleated' from the pericardium.
Fig 2 Modi®cation of a mitral regurgitation with heart manipulation. (A) When the heart is in its normal position, a trivial regurgitation is present. (B)
When the heart has been lifted up in a vertical position, the regurgitation has increased to a grade II.
Fig 3 Modi®cation of mitral shape with heart manipulation reconstructed in its three-dimensional aspect, as viewed from above (from reference 49,
with permission). (A) Normal saddle shape of the mitral ring when the heart is in its normal position. (B) When the heart is moved to the vertical
position, the mitral ring is severely distorted. (C) When the lifted heart is rotated to gain access to the lateral wall, the ring is further folded and
twisted.
Fig 4 The heart position using the technique of `rocking' with a tissue
stabilizer device. The right ventricle is squeezed between the left
ventricle and the right hemi-sternum; the right ventricular out¯ow tract is
compressed (courtesy of MedtronicsÔ).
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Surgical techniques
Strategies used by the surgeon to manipulate the heart
markedly in¯uence the haemodynamic response of the
patient. The numerous techniques described can be roughly
classi®ed into two categories: (i) heart `rocking' by a tissue
stabilizer device; and (ii) `enucleation' by pericardial
stitches.
The ®rst technique consists of displacing the heart with
gauze pads and/or rocking it with suction stabilizer devices.
In these conditions, the thin right ventricle (RV) is squeezed
between the pericardium and the bulky left ventricle, and
compressed under the right hemi-sternum, resulting in
severe haemodynamic compromise (Fig. 4).90 Transoeso-
phageal echocardiography reveals a bulging of the intera-
trial septum to the left, no dilatation of the LV, and part of
the cramped small RV with right out¯ow tract obstruction.90
In an animal model, GruÈndeman51 reported a 165% increase
in RV end-diastolic pressure and a 62% decrease in RV end-
diastolic area; LV pressures did not change although LV
diastolic cross-sectional area decreased by 20%. Opening of
the right pleura may reduce haemodynamic compromise.90
The Trendelenburg manoeuvre re-establishes the circula-
tory status and the coronary blood ¯ow at the expense of a
further rise in RV preload, an increased LV preload, and an
increased heart rate.50
The second technique consists of enucleating the heart by
aspirating the apex with a suction device, or by pulling the
posterior pericardium with multiple12 or single13 stitches.
The latter approach appears more attractive because of its
simplicity and ef®ciency. The stitch acts as a lever placed in
the oblique sinus of the pericardium, and the heart is
exposed by traction on the arms of a half-folded swab snared
down on the pericardium (Fig. 5). The arms are never pulled
across the heart in order to avoid any compression, which
may lead to functional compromise.13 99 The cardiac output
transiently collapses only when the heart is tipped over for
inserting the pericardial stitch. The stabilizing device is used
only to immobilize the local area of the anastomosis; it is
not used for positioning the heart nor for exposing the
cardiac wall.84 Even if the RV end-diastolic pressure is
elevated, the predominant haemodynamic effect is on the
Fig 5 Exposure of the heart with the posterior pericardial stitch of the
`no-touch' technique. (A) Location of the stitch in the oblique sinus of
the posterior pericardium on the right side of the spine, halfway between
the level of the right inferior pulmonary vein and the inferior vena
cava.13 Ideally, the stitch should be placed slightly to the right of the
spine (arrow); this allows TOE imaging from the oesophagus. (B) The
suture is passed through a half-folded swab and snared down, bringing
the folded end of the swab in close contact with the posterior
pericardium. For exposing a speci®c wall of the heart, both limbs of the
swab are pulled (arrows) in a direction opposite to the target wall with
the target artery located between both limbs, in order to avoid any
compression of the heart. This represents `no-touch' handling of the
heart.84 (C). In the ®nal position, the heart is enucleated from the
pericardium in a vertical position, the apex at the zenith; each cardiac
wall is accessible to surgery. On the picture, the tissue stabilizer is
applied on the posterior wall with minimal compression.
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left ventricle, with a 12±23% decline in LV stroke volume
and a 10±50% increase in left atrial ®lling pressure.78 121
The severity of the haemodynamic changes is linked to the
site of the anastomosis: it is more pronounced during
circum¯ex artery grafting, because lateral wall contraction
contributes more to stroke volume than does the posterior
wall, and because the tilting is more accentuated than for
left anterior descending artery grafting.78 84 121
Usually, the speed of heart positioning has more
dramatic effects than the displacement itself. Surgeon
and anaesthetist must therefore work in close collabor-
ation to ensure progressive positioning and rigorous
pressure adjustment.90 To improve surgical access to the
lateral and posterior walls of the heart, the operating
table is tilted to the right or positioned in the
Trendelenburg position, respectively. Leg elevation
appears the most ef®cient technique to improve preload.
Indeed, this manoeuvre increases the right atrial
transmural pressure, whereas the head-down position
increases intrathoracic pressure and right atrial pressure
similarly. Cardiac output is therefore increased with leg
elevation, but not in the head-down position.88 98
Intraoperative myocardial ischaemia
During OPCAB surgery, coronary artery cross-clamping to
ensure bloodless anastomotic conditions results in brief
periods of myocardial ischaemia, usually manifested by ST-
segment elevation and new regional wall motion abnormal-
ities (RWMA) on echocardiographic imaging.81 A 16 min
mean occlusion time of the left anterior descending artery
necessary to perform an anastomosis is associated with a
decrease in peak systolic shortening from 5.8% to 1.8%,18
and results in myocardial lactate production. The signi®-
cance of the ischaemia depends on the percentage stenosis
of the target vessel and of the degree of collateralization;
occlusion of highly collateralized vessels produces less
ischaemia than occlusion of `terminal' vessels.61 The most
intense ischaemic events occur when ¯ow is interrupted in a
discretely stenotic vessel, usually between 50 and 80%
stenosis, with poor collateralization.26 Severe ischaemia
during clamping of a non-occlusive right coronary artery
(RCA) can result in dangerous arrhythmias such as com-
plete atrioventricular (AV) block attributable to interruption
of the blood ¯ow in the AV node artery. Some surgeons
therefore favour revascularization of the RCA through distal
anastomoses placed beyond its bifurcation.41 84 Usually, it is
recommended to start the sequential anastomoses with the
most severely stenotic or occluded vessel.26 84
Different techniques are available in order to reduce the
consequences of coronary blood ¯ow interruption during
OPCAB surgery: improvement in myocardial oxygen
balance, ischaemic and pharmacological preconditioning,
pharmacological prophylaxis, and surgical shunting.
Improvement of myocardial oxygen balance
Improvement of myocardial oxygen balance can be
achieved by decreasing myocardial oxygen consumption
and/or increasing myocardial oxygen supply. A reduction in
oxygen consumption can be achieved through a decrease in
heart rate and contractility. This is usually realized by b-
blockers and calcium antagonists. With the verticalization
of the heart, LV wall tension remains low despite increasing
atrial ®lling pressures, as these pressures do not re¯ect the
actual end-diastolic pressure of the ventricle. Therefore, it
should not contribute to an increase in oxygen demand.
An adequate coronary perfusion pressure is crucial for
myocardial oxygen supply. Physiologically, aortic diastolic
pressure is the driving force for coronary perfusion.
Clinically, its closest measurement is the mean arterial
pressure (MAP) measured in the radial or femoral
artery.92 101 During anaesthesia with halogenated agents, a
MAP <65 mm Hg, or a coronary perfusion pressure <50 mm
Hg, are associated with intraoperative ischaemia,69 which is
in agreement with OPCAB literature, where the accepted
minimal MAP ranges from 60 mm Hg5 70 90 113 to 80 mm
Hg.41 It seems advisable to keep a MAP >70 mm Hg
allowing a safety margin above the critical coronary
perfusion pressure. This may be achieved by administration
of a vasopressor like phenylephrine or norepinephrine. A
lower value is acceptable as long as signs of ischaemia are
absent.
The aim is an overall equilibrium, where a low cardiac
output is tolerated in so far as it meets the demands of the
organism, as shown by an SvO2 >60%; the MAP is
maintained at or above 70 mm Hg without LV dilatation
as monitored by TOE. In order to prevent increased
myocardial oxygen demand when ischaemia is threatening,
b-stimulants are best avoided until complete revasculariza-
tion.
Preconditioning
Ischaemic preconditioning, or improvement of tolerance to
ischaemia by brief ischaemic bouts followed by reperfusion,
is an attractive technique for protecting the myocardium
during the obligatory period of myocardial ischaemia
required by OPCAB surgery.66 67 Preconditioning may
also be induced pharmacologically, which appears more
desirable in high-risk patients in whom an ischaemic type of
preconditioning may further jeopardize diseased myocar-
dium. Experimental studies have shown that volatile
anaesthetics such as iso¯urane or sevo¯urane protect the
myocardium against ischaemia by activation of a precondi-
tioning-like mechanism when administered at 2 minimum
alveolar concentration (MAC) at least 30 min before the
ischaemic insult.27 57 127 128 So far, preconditioning by
halogenated anaesthetics has been favourably evaluated
only in patients undergoing on-pump CABG sur-
gery.11 35 52 55 Propofol and etomidate, if used at clinically
relevant concentrations, should not affect the precondition-
ing mechanism.35 Collectively, these observations tend to
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indicate that administration of halogenated anaesthetics
may limit the adverse effects of ischaemic myocardial
damage.
Pharmacological prophylaxis
In patients suffering from coronary artery disease (CAD),
perioperative use of b-blocking agents has been shown to be
the most effective preventive measure.45 Possible bene®t
has been obtained with a2-agonists such as clonidine.86
Preoperative treatment of patients scheduled for coronary
revascularization is maintained and included in the
premedication. During the operation, a short-acting select-
ive b1-blocker like esmolol, given as repeated bolus or
continuous infusion, is very ef®cient in lowering excessive
heart rate.5 28 However, it might seriously reduce LV
function, as measured by a 42% decrease in mean arterial
pressure and a 35% drop in cardiac output, resulting in a
decrease in SvO2 from 81 to 65%.
28 This LV depression
leads to an increase in the pulmonary arterial pressure
(PAP), whereas right intraventricular pressure might already
be elevated because of right out¯ow tract compression or
sudden mitral regurgitation.
A calcium antagonist such as diltiazem may has some
theoretical advantages over b-blockers in the intraoperative
period. It has been shown that, for the same decrease in heart
rate, diltiazem lowers PAP, whereas esmolol tends to
increase it.28 In addition to reducing AV conduction and
heart rate as b-blockers do, calcium antagonists offer the
advantage of inducing vasodilation in arterial conduits.105
Moreover, as an increase in intracellular free calcium is one
of the primary causes of reperfusion injury and post-
ischaemic myocardial dysfunction, calcium antagonists
might prevent some post-ischaemic lesions.105 Some
centres administer a continuous infusion of diltiazem (0.1
mg kg±1 h±1) from incision to chest closure.28 84 91 However,
there is no objective evidence that calcium antagonists may
improve outcome in OPCAB surgery.
Magnesium ions, up to 20 mmol in the form of chloride or
sulphate, act similarly on myocardial cells; the only side-
effect is a slight arterial vasodilatation.44 Moreover, its use
during cardiac surgery tends to decrease the incidence of
atrial tachycardia.43 76 123 Some centres recommend the use
of MgCl2 or MgSO4 before pericardial opening.
76 84 106
Even if nitroglycerin prevents arterial spasm on isolated
human radial artery segments better than diltiazem, nitrates
have never been proven to be ef®cient in preventing
myocardial ischaemia during non-cardiac or conventional
cardiac procedures.47 107 In OPCAB studies, nitroglycerin
has been used to reduce pulmonary arterial pressure,15 to
treat active ischaemia,26 41 or as a hypothetical prophylactic
measure. However, the nitroglycerin-induced decrease in
preload is detrimental during heart verticalization when the
®lling pressures need to be increased to ensure optimal
ventricular ®lling. Metabolic support with an intravenous
glucose-insulin-potassium (GIK) solution does not offer
signi®cant clinical bene®t for myocardial protection during
OPCAB surgery.108
Surgical technique
In order to decrease the ischaemic time during anastomoses,
the surgeon can insert a small shunt (1±3 mm size) into the
coronary artery, which allows some blood ¯ow, suf®cient to
prevent segmental wall motion abnormalities and to
normalize or stabilize ST-segment elevation.73 When cor-
onary blood ¯ow is maintained during the grafting proced-
ure, only transient impairment of LV function is observed
during the anastomoses.125
Monitoring technique
Conventional 5-lead surface ECG with automated ST-
segment analysis is routine. However, heart manipulation
modi®es the positional relationships of the heart to the
surface electrodes, and restricts its contact with surrounding
tissues.90 The shape of the tracing is altered, and the
amplitude of the signal is reduced. For adequate monitoring
of myocardial ischaemia, a new baseline must be estab-
lished after each change in heart position in order to
correctly interpret the observed ECG changes. Nevertheless,
when the heart is completely enucleated, the diagnostic
accuracy of ECG monitoring is reduced.
Invasive arterial blood pressure monitoring is mandatory
to ensure adequate blood pressure. Of the studies reviewed,
74% consider a ¯oated pulmonary arterial catheter (PAC) to
be necessary. Right atrial and pulmonary wedge pressures
must be interpreted within the framework of heart
verticalization, as they should be signi®cantly increased in
order to push the blood up into the ventricle. SvO2 is a useful
tool to evaluate global tissue oxygenation: an SvO2 decrease
below 50% has been associated with the development of
bowel ischaemia.10 It is essential to maintain the tip of the
PAC in the mainstream of a large pulmonary artery, as the
handling of the heart might advance the tip of the catheter
into the periphery, towards smaller pulmonary vessels that
can be disrupted with balloon in¯ation.
During heart manipulation, RV and LV out¯ow might be
momentarily asymmetrical. The continuous pulse contour
cardiac output (PCCO), which provides a beat-to-beat
measurement of cardiac output from the arterial pulse
curve, might complete the data on cardiac pressures with
information on LV output. However, both PAC and PCCO
measurements have been found to be in close agreement.
The presence of air surrounding the heart, and the use of a
posterior pericardial stitch and swab close to the oesopha-
gus, restrict considerably the performance of TOE, particu-
larly when the heart is in the vertical position. The images
are usually of poor quality, although still interpretable. TOE
is a useful device for evaluating ventricular function and
effective ventricular end-diastolic volume, and for diagnos-
ing new RWMA. During coronary ¯ow interruption, new
RWMA are found in 64% of patients, of which 50% recover
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completely and 33% only partially after anastomosis.81
Mitral and pulmonary ¯ow changes, typical of moderate
diastolic impairment, can be observed during heart
verticalization along with a reduced size of the LV and
quantitative variation in mitral regurgitation.49 TOE can
also identify a patent foramen ovale, should an unexplained
refractory hypoxaemia supervene. It is also useful for
excluding intracavitary thrombus, which is a contraindica-
tion to beating heart surgery. As mortality and morbidity
from TOE are extremely low (0 and 0.2%, respectively),56
its risk±bene®t ratio makes it a valuable tool for monitoring
during OPCAB surgery.81 It is used routinely in 52% of the
reviewed series.
During the ®rst 30 min after revascularization, the surface
ECG frequently demonstrates signi®cant T-wave inversion
which might be linked to reperfusion injury.31 120
Quantitative bypass blood ¯ow measurement using an
ultrasound transit time ¯owmeter is therefore convenient
after the grafting procedure. The measured ¯ow should be
pulsatile and biphasic, with two forward components of
short protosystolic and large diastolic ¯ow, and one small
component of retrograde telesystolic ¯ow. The diastolic
¯ow velocity should be >15 cm s±1, and the mean graft ¯ow
at least 20 ml min±1.34 If the anastomosis is stenotic, the
¯ow curve becomes spiky and mainly systolic. Absolute
¯ow values are less signi®cant than the pulsatility index
(PI), which is obtained by dividing the difference between
the maximal and the minimal ¯ow by the mean ¯ow; the
optimal PI is between 1 and 5.34 A low ¯ow rate and an
augmented PI have a high prognostic value for mid-term
graft occlusion, and should lead to immediate graft recon-
struction.72 TOE is helpful in evaluating post-anastomosis
regional contractility. Persistent RWMA have an accurate
prognostic value for postoperative cardiac complications.81
Haemodynamic management
Knowing the haemodynamic patterns of the OPCAB
procedure, it becomes possible to adopt a strategy that
aims at maintaining an optimal myocardial oxygen balance.
This is usually achieved by keeping myocardial oxygen
consumption as low as possible, and by preserving a
relatively high coronary artery perfusion pressure (MAP
>70 mm Hg) with an infusion of vasopressor and an
increased preload.41 A reduced cardiac output is accepted as
long as the SvO2 remains >60% and metabolic acidosis does
not develop. The `Buf®ngton ratio' is a useful index. It
stipulates that patients suffering from coronary stenoses are
at particular risk of myocardial ischaemia when their mean
arterial pressure is less than the heart rate (MAP/heart rate
<1).19
The patient frequently becomes hypotensive when the
heart is tilted into a new position. Myocardial preload can be
increased by leg elevation,88 and by administration of ¯uids.
Total ¯uid input is surprisingly similar to that during CABG
performed on CPB. In our series, the mean amount of ¯uids
infused during OPCAB surgery was 850 6 230 ml of
colloid and 2800 6 800 ml of crystalloid.84 Alternatively,
a-adrenergic agents such as phenylephrine or norepinephr-
ine are indicated when MAP remains low despite optimiza-
tion of circulating blood volume, in order to prevent
excessive ¯uid administration and a detrimental increase in
lung water content. Many different regimens are used.
Possible LV dilatation is monitored by TOE. Excessive
heart rate is usually treated with a b-blocker, most
frequently esmolol, after exclusion of hypovolaemia or
inadequate anaesthesia. An a2-adrenoreceptor agonist like
dexmedetomidine might be useful in unresponsive cases.102
If excessive bradycardia (heart rate <50 min±1) develops,
Table 2 Suggested protocol for anaesthetic management of OPCAB surgery
Monitoring
ECG 5-lead plus continuous ST-segment analysis
Arterial catheter (femoral or radial)
Swan±Ganz pulmonary arterial catheter (through right internal jugular vein)
Two large-bore peripheral venous cannulae
TOE
Oesophageal and rectal temperatures, Foley catheter
Anaesthesia maintenance
Fentanyl (total dose 15±20 mg kg±1)
Vecuronium
Iso¯urane (1±1.5% throughout operation) or sevo¯urane (1.5±2.5%)
Tracheal intubation with single-lumen tube (double-lumen only in case of
thoracic approach)
Preventive measures
Room temperature set at 24°C
Fluid warming
Forced-air heating device, heating mattress
Diltiazem (0.1 mg kg±1 h±1) without loading dose, ®xed rate from skin
incision to sternum closure
Magnesium (MgCl2) 2±3 g i.v. at pericardial opening
500 ml of 6% hydroxyethyl starch 200/0.5 at pericardial opening
Auricular pacing wire connected to a pacemaker; ventricular lead added
during surgery on right coronary artery
Fluid management
Ringer's lactate and colloid perfusions as needed
Mannitol 0.5 gm kg±1 at the end of operation if ¯uid balance is
excessively positive
Blood transfusion trigger: 8 gm dl±1 (higher threshold values if obvious
ischaemia or central venous desaturation)
Blood loss processed by cell salvage
Hypotension
Leg elevation
Norepinephrine perfusion
Increase i.v. ¯uid administration
Heart rate up to 50±60 beats min±1 through atrial pacemaker if persistent
bradycardia
Low cardiac output (SvO2 <60%)
Increase heart rate with atrial pacemaker wire
Increase preload
As far as possible, no b-stimulation before revascularization
Intra-aortic balloon pump if LV acute failure
Indications for converting to CPB
Persistence of the followings for >15 min despite aggressive therapy:
Cardiac index <1.5 litre min±1 m±2
SvO2 <60%
MAP <50 mm Hg
ST-segment elevation >2 mV
Large new wall motion abnormalities or collapse of LV function
assessed by TOE
Sustained malignant arrhythmias
CPB=cardiopulmonary bypass; LV=left ventricular; MAP=mean arterial
pressure; TOE=transoesophageal echocardiography.
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pacemaker wires connected to the right atrium can be used
to increase the heart rate to 50±65 beats min±1.119 For main
RCA anastomoses, a ventricular wire must be in place to
avoid complete AV block. It seems advisable to avoid b-
stimulation before revascularization as myocardial ischae-
mia might increase because of excessive oxygen demand.
Although theoretically sound, this concept has not yet been
proven clinically in OPCAB surgery.90
Anticoagulation is mandatory during OPCAB surgery.
As there is no contact with foreign surfaces unlike CPB, the
targeted activated coagulation time (ACT) is usually kept at
250±300 s as in major vascular surgery.75 84 This is reached
by the i.v. administration of heparin 1±2 mg kg±1 (100±200
IU kg±1) before section of the internal mammary artery. The
ACT is repeated every 30 min, and heparin added as
required. This lesser degree of anticoagulation and the lower
platelet activation in comparison with CPB signi®cantly
decreases the haemorrhagic risk and the transfusion
rate.9 114 Heparin reversal with protamine is optional.
Mariani reported a hypercoagulable state after off-pump
procedures,75 which might put patients at risk of bypass
thrombosis or thromboembolism. Some centres start aspirin
and/or clopidogrel at the end of the procedure,1 as aspirin
reduces mortality and ischaemic complications after coron-
ary bypass surgery.74
Indications for conversion to CPB remain dif®cult to
de®ne (Table 2). The limits are usually set at the following
values, if they persist for >15 min despite aggressive
therapy: cardiac index <1.5 litre min±1 m±2, SvO2 <60%,
MAP <50 mm Hg, malignant arrhythmias, ST modi®cations
>2 mm, and/or complete cardiovascular collapse.91 The rate
of conversion to CPB varies between <1 and 4.9%.22 67 119
Good communication with the surgeon is essential, and the
repositioning of the heart is probably the ®rst step to take
before conversion.41 The presence of a perfusionist with a
`dry ready' CPB machine in the operating suite is therefore
current practice. The main factors associated with major
haemodynamic instability leading to CPB assistance are
cardiomegaly, lateral wall compression during anastomoses
on the obtuse marginal or ramus intermedius, and ischaemia
during main RCA grafting.119 In cases of severe LV
dysfunction (ejection fraction <20%), OPCAB can be
performed under the assistance of intra-aortic balloon
pumping in order to avoid CPB conversion.59 Flow-
controlled centrifugal or axial mini-pumps can offer a
right-side as well as a left-side support of 1±3 litre min±1.71
With experience, however, OPCAB has become a procedure
that can be performed without support, and these devices are
mainly used for short-term circulatory support in cases of
acute heart failure.
Anaesthesia technique
Avoiding CPB does not shorten the length of the procedure.
The duration depends largely on the number of anastomoses
performed and the skill of the surgical team. OPCAB,
however, accelerates immediate postoperative recovery.
This trend towards shorter ICU and hospital length of stay
has led anaesthetists to adapt their technique to a fast-track
management with early extubation (i.e. between 1 and 4 h
after the end of operation). This has been proven to be safe
and cost-effective.104 Hypothermia, as it constitutes an
independent predictor of morbid cardiac events,46 should be
avoided by all possible means during the operation: ¯uid
warming, a heat exchanger on the fresh gas ¯ow, warming
mattress etc. (Table 2). As much of the upper torso and
lower limbs are exposed during surgery, forced-air heating
devices are only marginally ef®cient; a room temperature up
to 24°C is usually recommended.26 40 68 Maintaining
normothermia is extremely challenging, as the absence of
CPB also removes the opportunity to warm up the patient on
bypass.
From a survey of 46 recent studies where the technique is
clearly described, the anaesthetic technique appears con-
ventional (Table 3): fentanyl, propofol or iso¯urane have
been used in about two-thirds of the institutions. In some
cases, general anaesthesia combined with intrathecal
(sufentanil-morphine or bupivacaine),14 or thoracic epidural
(bupivacaine) analgesia is favoured.2 40 68 91 Thoracic epi-
dural anaesthesia has been shown to increase the diameter of
epicardial arteries, increase collateral blood ¯ow, decrease
myocardial oxygen demand, decrease the incidence of
arrhythmias and the rate of chest infection, and provide
adequate postoperative analgesia.60 104 Despite the advan-
tages of cardiac sympatholysis for OPCAB surgery,
randomized studies comparing general vs combined anaes-
thesia, did not show signi®cant difference in patient
outcome, except for a trend towards earlier extuba-
tion.14 91 104 An ultra-fast technique with extubation in the
operating room does not seem to be of any additional bene®t
to the patient or to be cost-effective.40 82 As beating-heart
surgery requires less heparinization than CABG on CPB, the
risk of epidural haematoma is reduced compared with
conventional cardiac surgery, and should be the same as in
major vascular surgery. There is a trend to keep patients on
aspirin and antiplatelet drugs until surgery. Therefore, the
place of regional analgesia, although very attractive in
OPCAB surgery, needs to be further de®ned. Table 2
suggests an anaesthetic protocol; many other options may be
suitable or even better adapted to local practices.
Table 3 Main anaesthetic agents used for OPCAB surgery, as found in a
survey of 46 studies. Data are presented as the number (%) of times each
agent has been used
Propofol 25 (54)
Iso¯urane 19 (41)
Midazolam 8 (17)
Fentanyl 31 (67)
Sufentanil 11 (24)
Remifentanil 7 (15)
Epidural 4 (9)
Intrathecal 2 (4)
Chassot et al.
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Although anaesthetic technique has not been shown to
in¯uence postoperative mortality or morbidity in
OPCAB surgery patients, there is increasing experimen-
tal evidence that some anaesthetic agents may be more
suitable than others. Volatile anaesthetics such as
iso¯urane and sevo¯urane have been shown to induce
signi®cant pharmacological preconditioning, which rep-
resents protection against ischaemia.11 27 55 128 Although
i.v. anaesthesia maintains haemodynamic stability in
OPCAB surgery, propofol usually requires readjustment
of the loading conditions because of its venodilating
properties.103 In addition, it does not seem to have
signi®cant cardioprotective effects.35 When compared
with fentanyl and sufentanil, remifentanil markedly
reduces ventricular preload and heart rate.42
Nevertheless, well conducted randomized studies are
required to de®ne the most appropriate anaesthetic
protocol for OPCAB surgery. As haemodynamic stability
can be achieved with many different agents, those
mediating pharmacological preconditioning may be
favoured.55 128
Whatever the anaesthetic technique used, the primary
goals of the anaesthetist are to manage the haemodynamic
disturbances associated with heart manipulation and to treat
the ischaemic events caused by coronary occlusion. As the
difference in outcome of OPCAB vs CABG on CPB appears
mainly in high-risk cases, it is of the utmost importance for
the anaesthetist to master the pathophysiological processes
involved, because proper handling of compromised patients
could make a signi®cant difference to morbidity and
mortality.
Conclusions
OPCAB is an attractive alternative to on-pump surgery,
especially for patients with altered cardiac function and
severe comorbidities, including old age and coagulation
disorders. Anaesthetists involved in cardiac surgery must
have knowledge of this speci®c procedure and its haemo-
dynamic requirements. The primary goals of anaesthetic
management are maintenance of adequate haemodynamics
during heart enucleation and optimal myocardial protection
during ischaemic events. The anaesthetic technique con-
tributes to maintaining a stable equilibrium between
myocardial oxygen consumption and the oxygen require-
ments of the body. Experimental and clinical studies suggest
that halogenated agents have a protective effect against
ischaemia in myocardial cells, making them the anaesthetic
agent of choice. The place of thoracic epidural or intrathecal
analgesia, although promising, is not yet de®ned.
Anaesthetists play a proactive and integral part in the
success of the operative course and outcome of OPCAB
surgery, by their management of circulatory and ischaemic
disturbances.
Longer version of this review
A longer version of this review can be seen in British
Journal of Anaesthesia online. The ®gures also appear
online in colour as supplementary data.
To help clarifying the comparison between different
publications with dissimilar methodologies, the references
are annotated into levels of evidence according to the
guidelines of evidence-based medicine. Level I of evidence
contains studies with prospective, randomized selection of
patients, blinding and clear-cut results. Level II contains
controlled non-randomized prospective studies. Level III
comprises non-controlled non-randomized studies with
contemporaneous controls. Level IV corresponds to retro-
spective studies with historical controls. Level V includes
uncontrolled case series, observational studies and expert
opinions. Technical descriptions, review articles and meta-
analyses are not coded.
Addendum
Since acceptance of the manuscript, new prospective
randomized studies have been published focusing on two
crucial areas: clinical outcome after OPCAB surgery, and
preconditioning with volatile anaesthetics.
The reduction in transfusion requirements, in myocardial
injury as evidenced by troponin-I release, in length of ICU
and hospital stay, and in global costs, have all been
con®rmed by three randomized prospective studies.131±133
Morbidity and mortality are decreased in patients having
OPCAB compared to conventional CABG surgery in two
large comparative analyses of 7808 patients, the difference
being greater in high-risk patients.129±134 Neurological
dysfunction and stroke were also reduced in OPCAB
surgery compared with conventional CABG surgery in a
prospective randomized study on 60 patients.131
The bene®t of pharmacological preconditioning by
volatile anaesthetics55 128 has been con®rmed in a prospect-
ive randomized controlled clinical trial in patients under-
going OPCAB surgery.130 Patients receiving sevo¯urane
anaesthesia had less myocardial injury as evidenced by less
postoperative troponin-I release compared with patients
anaesthetized with propofol.130
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